TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bionomit Public AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
13
|
62
|
1 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-98
|
0
|
-3,117 |
| EBITDA |
-98
|
0
|
-49 |
| Total assets |
5,067
|
5,028
|
4,675 |
| Current assets |
93
|
97
|
45 |
| Current liabilities |
151
|
102
|
93 |
| Equity capital |
4,878
|
4,888
|
4,538 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.3%
|
97.2%
|
97.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-753.8%
|
0%
|
-311700% |
| Return on assets (ROA) |
-1.9%
|
0%
|
-66.7% |
| Current ratio |
61.6%
|
95.1%
|
48.4% |
| Return on equity (ROE) |
-2.0%
|
0%
|
-68.7% |
| Change turnover |
-50
|
61
|
-1 |
| Change turnover % |
-79%
|
6000%
|
-50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.